- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MDS Nordion announces big expansion
MDS Nordion of Kanata, Ontario, reported last month that it will enlarge its operations in a $12.3 million expansion that will include a 48,000-sq-ft building with space for radiopharmaceutical production, laboratories, packaging, shipping, and
MDS Nordion of Kanata, Ontario, reported last month that it will enlarge its operations in a $12.3 million expansion that will include a 48,000-sq-ft building with space for radiopharmaceutical production, laboratories, packaging, shipping, and warehousing. The company also plans to expand its cobalt-60 production facility by 5000 sq ft. The project will be complete by August 1999, according to the Canadian radiopharmaceutical firm. In addition to cobalt-60, MDS Nordion processes and distributes molybdenum that it receives from Atomic Energy of Canada (AECL).
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
